ACTRN12605000257662已完成3 期
A Follow-up Study to determine the efficacy and safety profile of a Pathway formulation in lowering lipid levels in primary hypercholesteremia over a 24-week period. of a Complementary Medicine Formulation in Primary Hypercholesterolemia
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Pathways
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 75 Years(—)
- 性别
- All
入选标准
- •1. LDL cholesterol ³3.5 and 5.7mmol/L 2. Body mass index 32kg/m23. Subject is willing to cease all medications over the course of the study, excluding medications for acute conditions such as pain or dyspepsia.
排除标准
- •1. Individuals with triglyceride levels >4mmol/L2. Individuals with a total cholesterol level >10 mmol/L3. Individuals with clinically abnormal liver function tests at baseline (measured at visit 2)4. Women who are pregnant or unwilling to use birth control for the period of the study5. Individuals with diabetes6. Individuals with hyperthyroidism7. Individuals with obstructive bile duct disease8. Individuals with metabolic disorders other than primary hypercholesterolaemia, includingphytosterolaemia9. Individuals who smoke10. Individuals with cardiovascular disease11. Subjects unwilling to comply with the study protocols12. Subjects with poor venous access13. Any other condition which in the opinion of the researchers could compromise the study.
研究者
相似试验
已完成
不适用
Open labelled, single arm, retrospective study of oral tofacitinib in vitiligoCTRI/2023/01/048849A40
招募中
Unknown
A retrospective study to evaluate the efficacy and safety of carbon ion radiation therapy for primary lung cancer.primary lung cancerJPRN-UMIN000052389ational institutes for Quatum Science and Technology150
已完成
2 期
Prospective study of evaluating the efficacy and safety of Radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastasescastration-resistant prostate cancer with bone metastasesJPRN-UMIN000023897ational Hospital Organization Saitama Hospital20
已完成
不适用
A retrospective study to explore the efficacy and safety of FOLFOX therapy and FOLFOX with radiation in esophageal squamous cell carcinomaesophageal squamous cell carcinomaJPRN-UMIN000047501ational Hospital Organization Nagoya Medical Center, Department of Medical Oncology143
进行中(未招募)
不适用
W-JHS NHL02-A studyPeripheral T-cell lymphoma (including extranodal NK/T-cell lymphoma)JPRN-jRCT1071210120Akashi Koichi20
